thiourea and Insect-Bites-and-Stings

As a follow-up of a preliminary trial, the therapeutic results obtained in 40 cases of acute and chronic dermatitis by the topical application of 10-undecen-1-yl-pseudothiourea hydroiodide (AHR-1911) in an evanescent vehicle containing triethanolamine stearate are presented. The treatment led to complete remission in 14/40 and to favorable results in 18/40 cases. In 2 out of 3 cases of infantile atopic dermatitis improvement was followed by relapse. The responsiveness to AHR-1911 of patients with delayed hypersensitivity, which requires steroids for treatment, is considered of clinical importance. The prompt action of the drug in acute dermatitis, such as is produced by insect-bites, appeared to be impressive. None of the total of 50 cases treated by the author with this new preparation showed any manifestation of intolerance or reaction to the drug.

Topics: Acute Disease; Administration, Topical; Adult; Anti-Inflammatory Agents; Child; Chronic Disease; Dermatitis; Dermatitis, Contact; Drug Evaluation; Ethanolamines; Humans; Infant; Insect Bites and Stings; Isothiuronium; Pharmaceutical Vehicles; Stearates; Thiourea

Topics: Administration, Topical; Adolescent; Adult; Burns; Bursitis; Child; Child, Preschool; Contusions; Female; Humans; Inflammation; Insect Bites and Stings; Isothiuronium; Male; Middle Aged; Ointments; Sprains and Strains; Tenosynovitis; Thiourea; Wounds and Injuries